Brief: Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
07/05/2024 14:20
May 7 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS ANNOUNCES REORGANIZATION OF EUROPEAN
OPERATIONS
AND SALE OF ENDOPREDICT BUSINESS
* MYRIAD GENETICS INC: TO SELL ITS ENDOPREDICT BUSINESS TO
EUROBIO
SCIENTIFIC
* MYRIAD GENETICS INC: WILL LICENSE EUROBIO RIGHT TO SELL
PROLARIS
IN VITRO DIAGNOSTIC KITS OUTSIDE U.S.
Source text for Eikon: ID:nGNX5K9qQZ
Further company coverage: MYGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple